Advanced Search

Journal of Traditional Chinese Medicine >

2023 , Vol. 43 >Issue 1: 140 - 145

DOI: https://doi.org/10.19852/j.cnki.jtcm.20221006.001

Original articles

Effects of Shengmai Yin (生脉饮) on pulmonary and cardiac function in coronavirus disease 2019 convalescent patients with cardiopulmonary symptoms: a randomized, double blind, multicenter control trial

  • Xuedong AN ,
  • Lina MAO ,
  • Ping XIA ,
  • Wen SU ,
  • Beibei WANG ,
  • Leiya KOU ,
  • Zequan ZHANG ,
  • Meng QI ,
  • Song HU ,
  • Jing CHEN ,
  • Xiujuan LI ,
  • Jinwei LIU ,
  • Juan ZHOU ,
  • Jie QIAO ,
  • Dan LUO ,
  • Guangwei LUO ,
  • Youqin YAN ,
  • Guiping YANG ,
  • Dandan DONG ,
  • Wei ZHOU ,
  • Junxiu TAO ,
  • De JIN ,
  • Xiaolin TONG ,
  • Li WEI
Expand
  • 1 Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    2 Department of Traditional Chinese Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    3 Department of Orthopedics, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    4 Department of Paediatrics, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    5 Department of Respiratory and Critical Care Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    6 Department of Pharmacy, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    7 Department of Geriatrics, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
    8 College of Traditional Chinese Medicine, Hubei University of Traditional Chinese Medicine, Wuhan 430060, China
    9 Department of Infectious Diseases, Wuhan No.7 Hospital, Wuhan 430071, China
    10 Department of Gastroenterology, Wuhan No.7 Hospital, Wuhan 430071, China
    11 Department of Gastroenterology, Xiaogan Traditional Chinese Medicine Hospital, Xiaogan 432100, China
    12 Department of Hepatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, China
    13 Institute of Metabolic Diseases, Guang’an Men Hospital of China Academy of Chinese Medical Sciences, Beijing 100053, China
    14 Department of Critical Care Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China
WEI Li, Department of Critical Care Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital), Wuhan 430022, China, e_weili@126.com. Telephone:+86-10-88001402; +86-27-85860666
TONG Xiaolin, Institute of Metabolic Diseases, Guang’an Men Hospital of China Academy of Chinese Medical Sciences, Beijing 100053, China, tongxiaolin@vip.163.com;

Received date: 2021-11-19

  Accepted date: 2022-02-19

  Online published: 2023-01-10

Supported by

Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study to Improve Symptoms Associated with Pulmonary Heart Function during Recovery from COVID-19 (II)(2020ZYLCYJ08-4)

Fold

Cite this article

Xuedong AN , Lina MAO , Ping XIA , Wen SU , Beibei WANG , Leiya KOU , Zequan ZHANG , Meng QI , Song HU , Jing CHEN , Xiujuan LI , Jinwei LIU , Juan ZHOU , Jie QIAO , Dan LUO , Guangwei LUO , Youqin YAN , Guiping YANG , Dandan DONG , Wei ZHOU , Junxiu TAO , De JIN , Xiaolin TONG , Li WEI . Effects of Shengmai Yin (生脉饮) on pulmonary and cardiac function in coronavirus disease 2019 convalescent patients with cardiopulmonary symptoms: a randomized, double blind, multicenter control trial[J]. Journal of Traditional Chinese Medicine, 2023 , 43(1) : 140 -145 . DOI: 10.19852/j.cnki.jtcm.20221006.001

References

1 Vellingiri B, Jayaramayya K, Iyer M, et al. COVID-19: a promising cure for the global panic. Sci Total Environ 2020; 725: 138277.
2 Ahn DG, Shin HJ, Kim MH, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 2020; 30: 313-24.
3 Tong XL, Li X, Zhao L, et al. Discussion on Traditional Chinese Medicine prevention and treatment strategies of coronavirus disease 2019 (COVID-19) from the perspective of “Cold-dampness Pestilence”. Zhong Yi Za Zhi 2020; 61: 465-70+553.
4 National Health Commission of the People’s Republic of China. Update on COVID-19 as of 24:00, 16 October (Chin). Published October 16, 2020. Accessed March 4, 2020 http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml.
5 Chen GH, Su W, Yang J, et al. Chinese herbal medicine reduces mortality in patients with severe and critical coronavirus disease 2019: a retrospective cohort study. Front Med 2020; 14: 752-9.
6 Turcu RP, Polich GR, Steere HK, Schneider JC, Borg-Stein J, Silver JK. Letter to the editor on "rehabilitation following critical illness in people with COVID-19 Infection". Am J Phys Med Rehabil 2020; 99: 787-8.
7 Tang XL, Liu L, Xiao W Y, et al. Research on the mechanism of Shengmai decoction against arrhythmia diseases based on molecular simulation. Shi Zhen Guo Yi Guo Yao 2019; 30: 2552-5.
8 Zhang Q. Effects of ShengMai Yin on pulmonary function, blood gas analysis and serum levels of TGF-β1, IL-6 and TNF-α in patients with COPD complicated by pulmonary interstitial fibrosis. Xian Dai Zhong Xi Yi Jie He Za Zhi 2020; 29: 534-7.
9 National Health Commission of the People’s Republic of China. Notice on the issuance of the fifth edition of the Diagnosis and Treatment Guideline for COVID-19 (Trial Version) (Chin). Published March 4, 2020.Accessed March 4, 2020 http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml.
10 Mo WL, Chai CZ, Kou JP, Yan YQ, Yu BY. Sheng-Mai-San attenuates contractile dysfunction and structural damage induced by chronic intermittent hypoxia in mice. Chin J Nat Med 2015; 13: 743-50.
11 Zhang YC, Chen RM, Lu BJ, Rong YZ. Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome. Chin J Integr Med 2008; 14: 107-10.
12 Ma S, Li X, Dong L, Zhu J, Zhang H, Jia Y. Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats. BMC Complement Altern Med 2016; 16: 61.
13 Zheng H, Chen Y, Chen J, Kwong J, Xiong W. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev 2011: CD005052.
14 Gong YB, Luo ZG, Gao SH, et al. Cross-sectional study on the relationship between formulas and syndromes of type 2 diabetes based on association rules. Zhong Yi Za Zhi 2010; 51: 64-7.
15 Huang X, Duan X, Wang K, Wu J, Zhang X. Shengmai injection as an adjunctive therapy for the treatment of chronic obstructive pulmonary disease: a systematic review and Meta-analysis. Complement Ther Med 2019; 43: 140-7.
Options
Outlines

/

〈 〉